Literature DB >> 12772225

Sputum induction as a diagnostic tool for community-acquired pneumonia in infants and young children from a high HIV prevalence area.

H J Zar1, E Tannenbaum, D Hanslo, G Hussey.   

Abstract

Sputum induction is a standard diagnostic procedure to identify pathogens in lower respiratory tract secretions in adults with pneumonia, but has rarely been studied or used in infants and young children. Our aim was to determine the usefulness of induced sputum (IS) as a diagnostic method for infants and children hospitalized with community-acquired pneumonia (CAP) in a high HIV prevalence area. Children hospitalized for CAP were prospectively enrolled over a year. IS was obtained by nebulization with hypertonic (5%) saline, physiotherapy, and suctioning. Sputum was submitted for bacterial and mycobacterial culture and P. carinii detection. Gastric lavages (GLs) were done for M. tuberculosis culture; a nasopharyngeal aspirate (NPA) was obtained for bacterial culture and P. carinii detection. IS was obtained in 210 children (median age, 7 (25th to 75th percentile, 3-18) months); 138 (66%) were HIV-infected; 148 (70%) were receiving supplemental oxygen. Bacteria were isolated from 101 (50%) IS and 141 (70%) NPA paired specimens (P < 0.001). A significantly higher rate of S. aureus, H. influenzae, M. catarrhalis, and S. pneumoniae was found in NPAs compared to IS; this pattern was particularly evident in HIV-infected children. M. tuberculosis was cultured from sputum in 19 patients (9%); GLs performed in 142 children were positive in only 9 (6%). The difference (95% confidence interval) between yields for M. tuberculosis from culture of IS compared to GL was 4.3% (95% CI, 0-5.6%; P = 0.08). P. carinii was identified from IS in 12 (5.7%) children; all corresponding NPAs were negative. Seven (3%) children could not tolerate sputum induction. Side effects included increased coughing in 4%, epistaxis in 3%, and wheezing responsive to bronchodilators in 1%. In conclusion, induced sputum is a useful and safe diagnostic procedure in infants and children with CAP from a high HIV prevalence area. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12772225     DOI: 10.1002/ppul.10302

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  19 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety.

Authors:  Margaret Rosenfeld; Stephanie Davis; Lyndia Brumback; Stephen Daniel; Ron Rowbotham; Robin Johnson; Sharon McNamara; Renee Jensen; Carol Barlow; Felix Ratjen
Journal:  Pediatr Pulmonol       Date:  2011-03-01

Review 3.  New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects.

Authors:  Mark P Nicol; Heather J Zar
Journal:  Paediatr Respir Rev       Date:  2010-10-16       Impact factor: 2.726

4.  Diagnosis of paediatric tuberculosis using sputum induction in Botswana: programme description and findings.

Authors:  D R Joel; A P Steenhoff; P C Mullan; B R Phelps; M A Tolle; A Ho-Foster; V Mabikwa; B G Kgathi; R Ncube; G M Anabwani
Journal:  Int J Tuberc Lung Dis       Date:  2014-03       Impact factor: 2.373

5.  Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study.

Authors:  Catherine M Samuel; Andrew Whitelaw; Craig Corcoran; Brenda Morrow; Nei-Yuan Hsiao; Marco Zampoli; Heather J Zar
Journal:  BMC Infect Dis       Date:  2011-11-28       Impact factor: 3.090

6.  Prevalence, risk factors and outcome of Mycoplasma pneumoniae infection among children in Uganda: a prospective study.

Authors:  Rebecca Nantanda; Freddie Bwanga; Irene Najjingo; Grace Ndeezi; James K Tumwine
Journal:  Paediatr Int Child Health       Date:  2021-11-08       Impact factor: 1.990

7.  Impact of HIV-1 status on the radiological presentation and clinical outcome of children with WHO defined community-acquired severe pneumonia.

Authors:  P M Jeena; A K Minkara; P Corr; F Bassa; L M McNally; H M Coovadia; M Fox; D H Hamer; D Thea
Journal:  Arch Dis Child       Date:  2007-06-26       Impact factor: 3.791

8.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

Review 9.  Advances in the diagnosis of pulmonary tuberculosis in HIV-infected and HIV-uninfected children.

Authors:  Tom G Connell; Heather J Zar; Mark P Nicol
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

10.  Risk of latent tuberculosis infection in children living in households with tuberculosis patients: a cross sectional survey in remote northern Lao People's Democratic Republic.

Authors:  Tuan H Nguyen; Peter Odermatt; Gunther Slesak; Hubert Barennes
Journal:  BMC Infect Dis       Date:  2009-06-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.